Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study)
Clinical trial NCT02096237 · COMPLETED
Trial details
- NCT number
- NCT02096237
- Sponsor
- Fresenius Medical Care Deutschland GmbH
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-07-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.